Caricamento...

Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration

BACKGROUND: Neovascular age-related macular degeneration (nAMD) has been treated with anti-vascular endothelial growth factor (anti-VEGF) therapy since 2006 with initial efficacy evidence of 2 years. In many, long-term therapy is required, and evidence for benefit is required from real-world data co...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Ophthalmol
Autori principali: Cheema, Muhammad Raza, DaCosta, Joanna, Talks, James
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2021
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7837532/
https://ncbi.nlm.nih.gov/pubmed/33519189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S269162
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !